US 11578081
Crystal form as inhibitor of ACC1 and ACC2, and preparation method therefor and use thereof
granted A61KA61K31/519A61P
Quick answer
US patent 11578081 (Crystal form as inhibitor of ACC1 and ACC2, and preparation method therefor and use thereof) held by Medshine Discovery Inc. expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Medshine Discovery Inc.
- Grant date
- Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/519, A61P, A61P3/04, A61P3/06